Skip to main content

Animations

MJFF Publications

1891 - 1900 of 6324 Results
Title
Year
  • Year
  • 2010
  • 2013
  • 2016
  • 2017
  • 2009
  • 2011
  • 2016
  • 2018
  • 2012
  • 2015
  • Summary Details
    OPEN
    Title: Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2010.09.001
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Expression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primates
    Journal Name: Neurological Research
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1179/1743132813y.0000000305
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Molecular tweezers for lysine and arginine – powerful inhibitors of pathologic protein aggregation
    Journal Name: Chemical Communications
    Publisher: Royal Society of Chemistry (RSC)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1039/c6cc04640a
    Citation Count: 127
  • Summary Details
    OPEN
    Title: Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study
    Journal Name: PLOS Medicine
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc0
    DOI - Digital Object Identifier: 10.1371/journal.pmed.1002314
    Citation Count: 178
  • Summary Details
    OPEN
    Title: Comparative Transduction Efficiency of AAV Vector Serotypes 1–6 in the Substantia Nigra and Striatum of the Primate Brain
    Journal Name: Molecular Therapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/mt.2009.286
    Citation Count: 127
  • Summary Details
    OPEN
    Title: In vivo demonstration that α-synuclein oligomers are toxic
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1100976108
    Citation Count: 1395
  • Summary Details
    OPEN
    Title: Fluorescent false neurotransmitter reveals functionally silent dopamine vesicle clusters in the striatum
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nn.4252
    Citation Count: 157
  • Summary Details
    OPEN
    Title: A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41593-018-0298-7
    Citation Count: 217
  • Summary Details
    OPEN
    Title: Fusion to a highly charged proteasomal retargeting sequence increases soluble cytoplasmic expression and efficacy of diverse anti-synuclein intrabodies
    Journal Name: mAbs
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.4161/mabs.21696
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Age-specific penetrance ofLRRK2G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000001708
    Citation Count: 158
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.